This study unveiled the pivotal role of ACTRIIB's N-glycosylation in the proliferation and invasion of NPC cells, providing new insights into the involvement of ACTRIIB in the onset and development of NPC and offering potential targets for the development of novel therapeutic strategies. Here, ACVR2B is linked to nasopharyngeal carcinoma.